Glioblastoma Multiforme: Probing Solutions to Systemic Toxicity towards High-Dose Chemotherapy and Inflammatory Influence in Resistance against Temozolomide

• Váldodahkkit: Sadia Nasir (Dahkki), Sadia Nazir (Dahkki), Rumeza Hanif (Dahkki), Aneela Javed (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2023-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Temozolomide (TMZ), the first-line chemotherapeutic drug against glioblastoma multiforme (GBM), often fails to provide the desired clinical outcomes due to inflammation-induced resistance amid inefficient drug delivery across the blood-brain barrier (BBB). The current study utilized solid lipid nano...